Document:

Exhibit

Exhibit 10.1

August 1, 2016

Compass Group Diversified Holdings LLC
61 Wilton Road
2nd Floor
Westport, Connecticut 06880
Attention:     Ryan Faulkingham
Chief Financial Officer

Re:    $150 Million Incremental Term Facility
Ladies and Gentlemen:
Reference is made to the Credit Agreement (as amended prior to the date hereof, the “Credit Agreement”) dated as of June 6, 2014 among Compass Group Diversified Holdings LLC, a Delaware limited liability company (“you” or the “Borrower”), the Lenders identified therein and Bank of America, N.A., as Administrative Agent.  Capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement.
You have advised Bank of America, N.A. (“Bank of America”) and Merrill Lynch, Pierce, Fenner & Smith Incorporated (or any of its designated affiliates, “MLPFS”) that you intend to acquire (the “Acquisition”) all of the equity interests of 5.11 Acquisition Corp., a Delaware corporation (the “Target”), from the existing shareholders of the Target (the “Sellers”).
You have also advised Bank of America and MLPFS that you intend to finance the Acquisition and the costs and expenses related to the Transaction (as hereinafter defined) from the following sources (and that no financing other than the financing described herein will be required in connection with the Transaction):  (a) $150 million term loan facility constituting an Incremental Tranche B Term Facility and (b) the remainder in Revolving Loans (the “Revolving Loan Borrowing”).  The Acquisition, the funding of the Incremental Term B Facility (defined below), the funding of the Revolving Loan Borrowing and all related transactions are hereinafter collectively referred to as the “Transaction”. 
In connection with the foregoing, Bank of America is pleased to advise you of its commitment to provide the full principal amount of an $150 million Incremental Tranche B Term Facility that is on identical terms as the outstanding Term Loan (the “Incremental Term B Facility”) and to act as the sole administrative agent (in such capacity, the “Administrative Agent”) for the Incremental Term B Facility, all upon and subject to the terms and conditions set forth in this letter (this “Commitment Letter”).  MLPFS is pleased to advise you of its willingness, as the sole lead arranger and sole bookrunner  (in such capacities, the “Lead Arranger”) for the Incremental Term B Facility, to form a syndicate of financial institutions and institutional lenders (including Bank of America) (collectively, the “Lenders”) in consultation with you for the Incremental Term B Facility. 
Bank of America will act as sole Administrative Agent for the Incremental Term B Facility and MLPFS will act as sole Lead Arranger for the Incremental Term B Facility.  No additional agents, co-agents or arrangers will be appointed and no other titles will be awarded without our prior written approval.  You hereby agree that, effective upon your acceptance of this Commitment Letter and continuing through January 29, 2017, you shall not solicit any other bank, investment bank, financial institution, person or entity to provide, structure, arrange or syndicate any component of 

the Incremental Term B Facility or any other senior financing similar to or as a replacement of any component of the Incremental Term B Facility.
The commitment of Bank of America hereunder and the undertaking of MLPFS to provide the services described herein are subject to the satisfaction of each of the conditions precedent set forth on Exhibit A hereto.
MLPFS intends to commence syndication of the Incremental Term B Facility promptly upon your acceptance of this Commitment Letter and the Fee Letter (defined below).  Until the earlier of (x) the date that a Successful Syndication (as defined in the Fee Letter) is achieved and (y) the date that is 90 days after the Closing Date (defined below) (such earlier date, the “Syndication Date”), you agree to actively assist MLPFS in achieving a syndication of the Incremental Term B Facility that is satisfactory to MLPFS and you.  Such assistance shall include your (a) providing and causing your advisors to provide Bank of America and MLPFS and the other Lenders upon request with all information reasonably deemed necessary by Bank of America and MLPFS to complete syndication, including, but not limited to, information and evaluations prepared by you, the Target and your and its advisors, or on your or its behalf, relating to the Transactions (including the Projections (as hereinafter defined), the “Information”), (b) assisting in the preparation of Information Memoranda and other materials to be used in connection with the syndication of the Incremental Term B Facility (collectively with any summary of terms prepared for distribution to Public Lenders (as hereinafter defined), the “Information Materials”), (c) using your commercially reasonable efforts to ensure that the syndication efforts of MLPFS benefit materially from your existing banking relationships, (d) procuring a rating for the Incremental Term B Facility from each of Standard & Poor’s Ratings Services and Moody’s Investors Service, Inc. prior to the launch of the syndication and (e) otherwise assisting Bank of America and MLPFS as reasonably requested in their syndication efforts, including by making your officers and advisors, and using commercially reasonable efforts to make the officers and advisors of the Target, reasonably available from time to time to attend and make presentations regarding the business and prospects of the Borrower and its subsidiaries at one or more meetings of prospective Lenders.
It is understood and agreed that MLPFS will manage and control all aspects of the syndication in consultation with you, including decisions as to the selection of prospective Lenders and any titles offered to proposed Lenders, when commitments will be accepted and the final allocations of the commitments among the Lenders.  It is understood that no Lender participating in the Incremental Term B Facility will receive compensation from you in order to obtain its commitment, except on the terms contained herein.  It is also understood and agreed that the amount and distribution of the fees among the Lenders will be at the sole and absolute discretion of Bank of America and MLPFS.
You represent, warrant and covenant that (a) all financial projections concerning the Borrower and its subsidiaries or the Target and its subsidiaries that have been or are hereafter made available to Bank of America, MLPFS or the Lenders by you, the Target or any of your or its representatives (or on your or its behalf) (the “Projections”) have been or will be prepared in good faith based upon reasonable assumptions and (b) all Information, other than Projections, which has been or is hereafter made available to Bank of America, MLPFS or the Lenders by you, the Target or any of your or its representatives (or on your or its behalf) in connection with any aspect of the Transactions, as and when furnished, is and will be complete and correct in all material respects and does not and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein not misleading.  You agree to furnish us with further and supplemental information from time to time until the later of (x) the date of the initial borrowing under the Incremental Term B Facility (the “Closing Date”) and (y) the Syndication Date so that the representation, warranty and covenant in the immediately preceding sentence are correct on the later of the Closing Date and the Syndication Date as if the Information were being furnished, and such representation, warranty and covenant were being made, on such date.  In issuing this commitment and in arranging and syndicating the Incremental Term B Facility, Bank of America and MLPFS are and will be using and relying on the Information without independent verification thereof.
You acknowledge that (a) MLPFS and/or Bank of America on your behalf will make available Information Materials to the proposed syndicate of Lenders by posting the Information Materials on IntraLinks, SyndTrak or another similar electronic system and (b) certain prospective Lenders (such Lenders, “Public Lenders”; all other Lenders, “Private Lenders”) may have personnel that do not wish to receive material non-public information (within the meaning of the United States federal securities laws, “MNPI”) with respect to you, the Target or your or its affiliates, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with 

respect to such entities’ securities.  If requested, you will assist us in preparing an additional version of the Information Materials not containing MNPI (the “Public Information Materials”) to be distributed to prospective Public Lenders.
At our request, before distribution of any Information Materials (a) to prospective Private Lenders, you shall provide us with a customary letter authorizing the dissemination of the Information Materials and (b) to prospective Public Lenders, you shall provide us with a customary letter authorizing the dissemination of the Public Information Materials and confirming the absence of MNPI therefrom.  In addition, at our request, you shall identify Public Information Materials by clearly and conspicuously marking the same as “PUBLIC”.
You agree, so long as you are the issuer of any outstanding debt or equity securities that are registered or issued pursuant to a private offering or are actively contemplating issuing any such securities, that MLPFS and/or Bank of America on your behalf may distribute the following documents to all prospective Lenders, unless you advise MLPFS and Bank of America in writing (including by email) within a reasonable time prior to their intended distributions that such material should only be distributed to prospective Private Lenders:  (a) administrative materials for prospective Lenders such as lender meeting invitations and funding and closing memoranda, (b) notifications of changes to Incremental Term B Facility’s terms and (c) other materials intended for prospective Lenders after the initial distribution of the Information Materials, including drafts and final versions of definitive documents with respect to the Incremental Term B Facility.  If you advise us that any of the foregoing items should be distributed only to Private Lenders, then MLPFS and Bank of America will not distribute such materials to Public Lenders without further discussions with you.  You agree (whether or not any Information Materials are marked “PUBLIC”) that Information Materials made available to prospective Public Lenders in accordance with this Commitment Letter shall not contain MNPI.
By executing this Commitment Letter, you agree to reimburse Bank of America and MLPFS from time to time on demand for all reasonable out-of-pocket fees and expenses (including, but not limited to, (a) the reasonable fees, disbursements and other charges of Moore & Van Allen, PLLC, as counsel to the Lead Arranger and the Administrative Agent, and (b) reasonable due diligence expenses) incurred in connection with the Incremental Term B Facility, the syndication thereof, the preparation of the definitive documentation therefor and the other aspect of the Transactions. You acknowledge that we may receive a benefit, including without limitation, a discount, credit or other accommodation, from any of such counsel based on the fees such counsel may receive on account of their relationship with us including, without limitation, fees paid pursuant hereto.
You agree to indemnify and hold harmless Bank of America, each Lender, MLPFS and each of their affiliates and their respective officers, directors, employees, agents, advisors and other representatives (each, an “Indemnified Party”) from and against (and will reimburse each Indemnified Party as the same are incurred for) any and all claims, damages, losses, liabilities and expenses (including, without limitation, the reasonable fees, disbursements and other charges of counsel) that may be incurred by or asserted or awarded against any Indemnified Party, in each case arising out of or in connection with or by reason of (including, without limitation, in connection with any investigation, litigation or proceeding or preparation of a defense in connection therewith) (a) any aspect of the Transactions or (b) the Incremental Term B Facility, or any use made or proposed to be made with the proceeds thereof, except to the extent such claim, damage, loss, liability or expense is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful misconduct.  In the case of an investigation, litigation or proceeding to which the indemnity in this paragraph applies, such indemnity shall be effective whether or not such investigation, litigation or proceeding is brought by you, your equity holders or creditors or an Indemnified Party, whether or not an Indemnified Party is otherwise a party thereto and whether or not any aspect of the Transactions is consummated.  You also agree that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to you or your subsidiaries or affiliates or to your or their respective equity holders or creditors arising out of, related to or in connection with any aspect of the Transactions, except to the extent of direct, as opposed to special, indirect, consequential or punitive, damages determined in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful misconduct.  Notwithstanding any other provision of this Commitment Letter, no Indemnified Party shall be liable for any damages arising from the use by others of information or other materials obtained through electronic telecommunications or other information transmission systems, other than for direct or actual damages resulting from the gross negligence or willful misconduct of such Indemnified Party as determined by a final and non-appealable judgment of a court of competent jurisdiction.

This Commitment Letter and the fee letter among you, Bank of America and MLPFS of even date herewith (the “Fee Letter”) and the contents hereof and thereof are confidential and, except for disclosure hereof or thereof on a confidential basis to your accountants, attorneys and other professional advisors retained by you in connection with the Incremental Term B Facility or as otherwise required by law, may not be disclosed by you in whole or in part to any person or entity without our prior written consent; provided, however, it is understood and agreed that you may disclose this Commitment Letter but not the Fee Letter (a) on a confidential basis to the board of directors and advisors of the Target and the Sellers in connection with their consideration of the Acquisition and (b) after your acceptance of this Commitment Letter and the Fee Letter, in filings with the Securities and Exchange Commission and other applicable regulatory authorities and stock exchanges.  Bank of America and MLPFS hereby notify you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “Act”), each of them is required to obtain, verify and record information that identifies you, which information includes your name and address and other information that will allow Bank of America or MLPFS, as applicable, to identify you in accordance with the Act.
Each of Bank of America and MLPFS shall use all confidential information provided to them by or on behalf of you hereunder solely for the purpose of providing the services which are the subject of this Commitment Letter and otherwise in connection with the Transaction and shall treat confidentially all such information; provided, however, that nothing herein shall prevent either Bank of America or MLPFS from disclosing any such information (i) pursuant to the order of any court or administrative agency or in any pending legal or administrative proceeding, or otherwise as required by applicable law or compulsory legal process (in which case Bank of America and MLPFS agree to inform you promptly thereof prior to such disclosure to the extent not prohibited by law, rule or regulation), (ii) upon the request or demand of any regulatory authority having jurisdiction over Bank of America, MLPFS or any of their respective affiliates, (iii) to the extent that such information becomes publicly available other than by reason of disclosure in violation of this agreement by Bank of America or MLPFS, (iv) to Bank of America’s and MLPFS’ respective affiliates, and their and such affiliates’ respective employees, legal counsel, independent auditors and other experts or agents who need to know such information in connection with the Transaction and are informed of the confidential nature of such information, (v) for purposes of establishing a “due diligence” defense, (vi) to the extent that such information is or was received by Bank of America or MLPFS from a third party that is not to Bank of America’s or MLPFS’ knowledge subject to confidentiality obligations to you, (vii) to the extent that such information is independently developed by Bank of America or MLPFS or (viii) to potential Lenders, participants, assignees or potential counterparties to any swap or derivative transaction relating to the Borrower or any of its subsidiaries or any of their respective obligations, in each case, who agree to be bound by the terms of this paragraph (or language substantially similar to this paragraph or as otherwise reasonably acceptable to you and Bank of America and MLPFS, including as may be agreed in any confidential information memorandum or other marketing material).  This paragraph shall terminate on the first anniversary of the date hereof. 

You acknowledge that Bank of America and MLPFS or their affiliates may be providing financing or other services to parties whose interests may conflict with yours.  Bank of America and MLPFS agree that they will not furnish confidential information obtained from you to any of their other customers and that they will treat confidential information relating to you and your affiliates with the same degree of care as they treat their own confidential information.  Bank of America and MLPFS further advise you that they will not make available to you confidential information that they have obtained or may obtain from any other customer.  In connection with the services and transactions contemplated hereby, you agree that Bank of America and MLPFS are permitted to access, use and share with any of their bank or non-bank affiliates, agents, advisors (legal or otherwise) or representatives any information concerning you or any of your affiliates that is or may come into the possession of Bank of America, MLPFS or any of such affiliates.  
In connection with all aspects of each transaction contemplated by this Commitment Letter, you acknowledge and agree, and acknowledge your affiliates’ understanding, that:  (a) (i) the arranging and other services described herein regarding the Incremental Term B Facility are arm’s-length commercial transactions between you and your affiliates, on the one hand, and Bank of America and MLPFS, on the other hand, (ii) you have consulted your own legal, accounting, regulatory and tax advisors to the extent you have deemed appropriate, and (iii) you are capable of evaluating, and understand and accept, the terms, risks and conditions of the transactions contemplated hereby; (b) (i) Bank of America and MLPFS each has been, is, and will be acting solely as a principal and, except as otherwise expressly agreed in 

writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for you, any of your affiliates or any other person or entity and (ii) neither Bank of America nor MLPFS has any obligation to you or your affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein; and (c) Bank of America and MLPFS and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from yours and those of your affiliates, and Bank of America and MLPFS have no obligation to disclose any of such interests to you or your affiliates. To the fullest extent permitted by law, you hereby waive and release any claims that you may have against Bank of America and MLPFS with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated by this Commitment Letter.
This Commitment Letter and the Fee Letter shall be governed by, and construed in accordance with, the laws of the State of New York.  Each of you, Bank of America and MLPFS hereby irrevocably waives any and all right to trial by jury in any action, proceeding or counterclaim (whether based on contract, tort or otherwise) arising out of or relating to this Commitment Letter, the Fee Letter, the Transactions and thereby or the actions of Bank of America and MLPFS in the negotiation, performance or enforcement hereof.  Each of Bank of America, MLPFS and you hereby irrevocably and unconditionally submits to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in the Borough of Manhattan in New York City in respect of any suit, action or proceeding arising out of or relating to the provisions of this Commitment Letter, the Fee Letter and the Transactions and irrevocably agrees that all claims in respect of any such suit, action or proceeding may be heard and determined in any such court. Nothing in this Commitment Letter or the Fee Letter shall affect any right that Bank of America, MLPFS or any affiliate thereof may otherwise have to bring any claim, action or proceeding relating to this Commitment Letter, the Fee Letter and/or the Transactions in any court of competent jurisdiction to the extent necessary or required as a matter of law to assert such claim, action or proceeding against any assets of the Borrower or any of its subsidiaries or enforce any judgment arising out of any such claim, action or proceeding.  Each of Bank of America, MLPFS and you agree that service of any process, summons, notice or document by registered mail addressed to you shall be effective service of process against you for any suit, action or proceeding relating to any such dispute.  Each of Bank of America, MLPFS and you waives, to the fullest extent permitted by applicable law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceedings brought in any such court, and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.  A final judgment in any such suit, action or proceeding brought in any such court may be enforced in any other courts to whose jurisdiction you are or may be subject by suit upon judgment.  The commitments and undertakings of Bank of America and MLPFS may be terminated by us if you fail to perform your obligations under this Commitment Letter or the Fee Letter on a timely basis.
The provisions of the immediately preceding seven paragraphs shall remain in full force and effect regardless of whether any definitive documentation for the Incremental Term B Facility shall be executed and delivered, and notwithstanding the termination of this Commitment Letter or any commitment or undertaking of Bank of America or MLPFS hereunder.
This Commitment Letter and the Fee Letter may be executed in counterparts which, taken together, shall constitute an original.  Delivery of an executed counterpart of this Commitment Letter or the Fee Letter by telecopier, facsimile or other electronic means (such as by email in “pdf” format) shall be effective as delivery of a manually executed counterpart thereof.
This Commitment Letter and the Fee Letter embody the entire agreement and understanding among Bank of America, MLPFS, you and your affiliates with respect to the Incremental Term B Facility and supersedes all prior agreements and understandings relating to the specific matters hereof.  However, please note that the terms and conditions of the commitment of Bank of America and the undertaking of MLPFS hereunder are not limited to those set forth herein.  Those matters that are not covered or made clear herein or the Fee Letter are subject to mutual agreement of the parties.  No party has been authorized by Bank of America or MLPFS to make any oral or written statements that are inconsistent with this Commitment Letter.  This Commitment Letter is not assignable by the Borrower without our prior written consent and is intended to be solely for the benefit of the parties hereto and the Indemnified Parties; provided, that MLPFS may, without notice to the Borrower, assign its rights and obligations under this Commitment Letter to any other registered broker-dealer wholly-owned by Bank of America Corporation to which all or substantially all of Bank 

of America Corporation’s or any of its subsidiaries’ investment banking, commercial lending services or related businesses may be transferred following the date of this Commitment Letter.
This Commitment Letter and all commitments and undertakings of Bank of America and MLPFS hereunder will expire at 11:59 p.m. Eastern time on August 1, 2016 unless you execute this Commitment Letter and the Fee Letter and return them to us prior to that time (which may be by facsimile transmission), whereupon this Commitment Letter and the Fee Letter (each of which may be signed in one or more counterparts) shall become binding agreements.  Thereafter, all commitments and undertakings of Bank of America and MLPFS hereunder will expire on the earliest of (a) October 29, 2016, unless the Closing Date occurs on or prior thereto, (b) the closing of the Acquisition without the use of the Senior Credit Facilities and (c) the acceptance by the Target or any of its affiliates of an offer for all or any substantial part of the capital stock or property and assets of the Target and its subsidiaries other than as part of the Acquisition.
[SIGNATURE PAGES FOLLOW]

We are pleased to have the opportunity to work with you in connection with this important financing.
Very truly yours,
BANK OF AMERICA, N.A.

By:    /s/ Christopher T. Phelan                
Name:   Christopher T. Phelan
Title:    Senior Vice President

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED 

By:    /s/ James Dallas                
Name:    James Dallas
Title:    Director

Accepted and agreed to as of the date first above written:

COMPASS GROUP DIVERSIFIED HOLDINGS LLC, a Delaware limited liability company

By:    /s/ Ryan Faulkingham                
Name:    Ryan Faulkingham
Title:    Chief Financial Officer

EXHIBIT A

CONDITIONS PRECEDENT TO INCREMENTAL TERM B FACILITY

Capitalized terms not otherwise defined herein have the same meanings as specified therefor in the Commitment Letter to which this Exhibit A is attached (the “Commitment Letter”).

The advance of the Incremental Term B Facility will be subject to satisfaction of each of the following:
(a)    Amendment Documentation.  The negotiation, execution and delivery of an Incremental Facility Amendment for the Incremental Term B Facility by the Borrower, the Administrative Agent and Bank of America.
(b)    Satisfaction of Conditions under the Credit Agreement.  The satisfaction of each of the conditions to the establishment and funding of the Incremental Term B Facility as an “Incremental Tranche B Term Facility” under Section 2.01(c) of the Credit Agreement as in effect on the date of the Commitment Letter and the satisfaction of each of the conditions to funding the Incremental Term B Facility in Section 4.02 of the Credit Agreement as in effect on the date of the Commitment Letter.
(c)    Funding of Revolving Loans under the Credit Agreement.  The Revolving Loan Borrowing shall have been, or shall concurrently with the funding of the Incremental Term B Facility be, funded to the Borrower.
(d)    Acquisition.
(i)    The Acquisition shall have been, or shall concurrently with the funding of the Incremental Term B Facility be, consummated in accordance with the terms of the Agreement and Plan of Merger dated as of July 29, 2016 the Borrower, 5.11 ABR Corp., 5.11 ABR Merger Corp. (“Merger Sub”), the Target and TA Associates Management, L.P., as Securityholders’ Agent (as may, subject to paragraph (d)(ii) below, be amended, supplemented or other modified from time to time, the “Acquisition Agreement”) and the other documents, agreements and instruments relating thereto (together with the Acquisition Agreement, the “Acquisition Documents”), and the Administrative Agent shall have received evidence satisfactory to it that merger of Merger Sub with and into the Company is, or shall concurrently with the funding of the Incremental Term B Facility be,  effective.
(ii)    The Acquisition Documents shall not be altered, amended or otherwise changed or supplemented or any condition therein waived in any manner that would be materially adverse to the Lenders in their capacities as such without the prior written consent of the Administrative Agent.  For purposes of the foregoing condition, it is hereby understood and agreed that any increase or decrease in the aggregate purchase price by more than 10% shall be deemed to be materially adverse to the Lenders. 
(iii)    The representations and warranties made by or on behalf of the Target in the Acquisition Documents and which are material to the interests of the Lenders (in their capacities as such) shall be true and correct in all material respects (or, with respect to representations already qualified by concepts of materiality, in all respects) as of the Closing Date, but only to the extent that the Borrower or any of its affiliates has the right to terminate its obligations under the Acquisition Documents or to decline to consummate the Acquisition as a result of a breach of such representations and warranties in the Acquisition Documents. 
(iv)    Since the date of Acquisition Agreement, there shall not have been any event, occurrence, state of facts, circumstance, condition, effect or change that has had or would be reasonably expected to have, individually or in the aggregate, a “Material Adverse Effect”.  Solely for purposes of this clause (vi)  “Material Adverse Effect” has the meaning assigned to such term in the Acquisition Agreement.
(v)    All indebtedness of the Target and its subsidiaries (other than indebtedness permitted by the Credit Agreement) shall have been repaid (or substantially concurrently with the funding of the Incremental 

Term B Facility on Closing Date shall be repaid), all commitments with respect thereto shall have been terminated (or substantially concurrently with the funding of the Incremental Term B Facility on Closing Date be terminated) and all liens and security interests securing such indebtedness (other than liens and security interests permitted by the Credit Agreement) shall have been released or terminated (or substantially concurrently with funding of the Incremental Term B Facility on Closing Date shall be released or terminated), or arrangements satisfactory to the Administrative Agent shall have been made with respect to the foregoing.
(vi)    The Administrative Agent shall have received an executed copy of the Acquisition Agreement (including any amendments thereto) and each other primary Acquisition Document requested by the Administrative Agent, in each case with all schedules and exhibits thereto.
(e)    Solvency Certificate.  The Administrative Agent shall have received certification from the chief financial officer of the Borrower as to the solvency of the Borrower and its Subsidiaries on a consolidated basis in each case after giving effect to the Transactions.
(f)    Ratings.  The Term Loan (after giving effect to the advance of the Incremental Term B Facility as a part of the Term Loan) shall have received a rating from each of Moody’s and S&P and the Borrower shall have received a corporate family/corporate credit rating from each of Moody’s and S&P. 
(g)    Marketing Period.  The Closing Date shall not occur less than twenty (20) business days (the “Marketing Period”) after the receipt of customary information for completion of the Information Memorandum reasonably requested by the Lead Arranger (the “Required Information”).  If at any time you shall in good faith believe that you have provided the Required Information, you may deliver to the Lead Arranger written notice to that effect (stating when you believe you completed any such delivery), in which case you shall be deemed to have delivered the Required Information on the date of such notice and the Marketing Period shall be deemed to have commenced on the date of such notice, unless the Lead Arranger in good faith reasonably believes that you have not completed delivery of the Required Information and, within three (3) business days to that effect (stating with specificity which information you have not delivered for purposes of compliance with this condition only, in which case the Marketing Period shall be deemed to have commenced when such specific items are delivered) (provided that it is understood that the delivery of such written notice from the Lead Arranger to you will not prejudice your right to assert that the Required Information has in fact been delivered).

(i)    Know Your Customer.      The Administrative Agent shall have received at least three business days prior to the Closing Date all documentation and other information requested by any Lender in writing at least five business days prior to the Closing Date that such Lender determines is required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation the PATRIOT Act.
(j)    Fees.  All fees required to be paid on the Closing Date pursuant to the Fee Letter shall have been paid.
(k)    Expenses.  All expenses of the Administrative Agent and the Lead Arranger payable pursuant to the Commitment Letter shall have been paid to the extent invoiced at least one business day prior to the Closing Date.EX-10.1

 Exhibit 10.1 

SEPARATION AGREEMENT 

This Separation Agreement (this “Agreement”) is made and entered into as of August 1, 2016 (the “Effective
Date”), by and between Robert Fair (the “Executive”) and Teradata Corporation (the “Company”). The Company and Executive are sometimes collectively referred to herein as the Parties and individually as a
Party. As used in this Agreement, the term “affiliate” shall mean any entity controlled by, controlling, or under common control with, the Company. 

WHEREAS, Executive and the Company have determined to provide for the termination of Executive’s employment with the Company and
its affiliates on the terms and subject to the conditions set forth herein. 
 NOW, THEREFORE, in consideration of the foregoing
recitals, the mutual promises contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties hereto agree as follows: 

1. Separation. Executive shall cease to be the Chief Operating Officer of the Company as of the Effective Date, but shall continue to
serve as an employee of the Company from the Effective Date through November 1, 2016 (the “Separation Date”) at his base salary level in effect as of the Effective Date, and shall conscientiously and in good faith make efforts
to facilitate the successful transition of the individuals who take on a position that relates to Executive’s area of responsibility, assist with the transition of the Teradata Marketing Applications business to Marlin Equity Partners, and
perform such other duties as may from time-to-time be specified by the Company’s President and Chief Executive Officer. Effective as of the Separation Date, Executive’s employment with the Company and its affiliates shall end and Executive
shall cease to be an employee and officer of any and all of the foregoing without any further action or notice. In addition, effective as of as the Separation Date, or before such time if requested in writing by the Company’s Secretary and
General Counsel, Executive hereby resigns from (a) any and all directorships Executive may hold with the Company’s affiliates and (b) all positions Executive may hold with any other entities for which the Company or its affiliates
have requested Executive to perform services. Executive hereby agrees to execute any and all documentation to effectuate such resignations upon request by the Company, but he shall be treated for all purposes as having so resigned on the Separation
Date, regardless of when or whether he executes any such documentation. 
 2. Accrued Benefits. The Company will pay and provide to
Executive the following payments and benefits: 
 (a) Salary and Vacation Pay. Within 7 calendar days after the Separation Date, or
such earlier date as required by law, the Company will issue to Executive his final paycheck, reflecting (i) his earned but unpaid base salary through the Separation Date, and (ii) his accrued but unused vacation pay through the Separation
Date. 
 (b) Expense Reimbursements. Within 30 calendar days following the Separation Date, the Company will reimburse Executive for
any reasonable unreimbursed business expenses actually and properly incurred by Executive in connection with carrying out 

  
 1 

 
his duties with the Company through the Separation Date in accordance with the Company’s applicable business expense reimbursement policies, which expenses will be submitted by Executive to
the Company with supporting receipts and/or documentation no later than 10 calendar days after the Separation Date. 
 (c) Other
Benefits. All Company-provided benefits shall cease to accrue on the Separation Date, including but not limited to accrual of vacation, short or long-term disability leave, and other benefits. To the extent not theretofore paid or provided, the
Company shall pay or provide, or cause to be paid or provided, to Executive any amounts or benefits required to be paid or provided or which Executive is eligible to receive under the Company’s (or an affiliate’s) retirement plans or
welfare benefit plans, in each case in accordance with the terms, conditions and normal procedures of each such plan and based on accrued and vested benefits through the Separation Date. The Company will continue to provide the existing level of
health and dental insurance benefits through the Separation Date and will subsidize Executive’s health insurance under COBRA for eighteen months at the current contribution rate, as further discussed in Section 3(c) below. Executive will
receive information regarding election of benefit continuation separately. 
 3. Severance Benefits. In consideration of, and subject
to and conditioned upon Executive’s timely execution and non-revocation of the general release attached as Exhibit A to this Agreement and incorporated herein (the “Release”) and the effectiveness of such Release as
provided in Section 4 of this Agreement, and provided that Executive has fully complied with his obligations set forth in Section 6 of this Agreement, the Company will pay or provide to Executive the following payments and benefits, which
Executive acknowledges and agrees constitute adequate and valuable consideration, in and of themselves, for the promises contained in this Agreement. The amounts due under this Section 3 shall not be subject to offset for compensation earned by
Executive from another employer, provided that Executive remains in full compliance with Section 6 hereof. 
 (a) Severance. The
Company shall pay to Executive an amount equal to $1,472,625, payable in equal installments in accordance with the Company’s normal payroll procedures over the fifteen-month period following the Separation Date, with the first installment
commencing on the first payroll date to occur on or immediately after the date the Release becomes effective and irrevocable in accordance with its terms. The first installment shall include all amounts accrued after the Separation Date to the date
of such installment and the remaining installments shall be payable as otherwise scheduled assuming that payments had begun on the first regular payroll date after the Separation Date. 

(b) Annual Incentive. Executive will be eligible to receive an annual incentive for fiscal 2016 under the Company’s 2016 annual
bonus program of the Management Incentive Plan on the same terms as other participating Company employees, based on actual performance of the Company in fiscal year 2016 relative to Company objectives established under such 2016 annual bonus
program, without regard to any discretionary adjustments that have the effect of reducing the amount of the annual incentive below the amount earned based on the achievement of such Company objectives, and pro-rated for the number of days employed
during 2016 through and including the Separation Date. The annual incentive shall be payable in a single lump sum at the same time that payments are made to other participants in the Company’s Annual Incentive Plan for the fiscal year (pursuant
to the terms of the plan but in no event later than March 15, 2017). 

  
 2 

 (c) Health Insurance Coverage. If Executive timely elects continued health and dental
coverage under COBRA, the Company will subsidize Executive’s COBRA premiums to continue his coverage (including coverage for his eligible dependents, if applicable) (the “COBRA Premiums”), such that Executive will only be
obligated to pay the contributions required of active employees for the eighteen-month period starting on the Separation Date (the “COBRA Premium Period”). The COBRA Premium Period runs concurrently with the COBRA continuation
period. During the period the Company provides Executive with this coverage, an amount equal to the applicable COBRA Premiums (or such other amounts as may be required by law) will be included in Executive’s income for tax purposes to the
extent required by applicable law and the Company may withhold taxes from Executive’s other compensation for this purpose. The Company specifically reserves the right at its sole discretion to amend, suspend, discontinue or terminate the health
and dental plan or any or all benefits under the plan at any time, without either the prior consent of, or any prior notice to, any employee, and to make or amend rules for administration of the plan; provided, however, that if the Company
terminates its health and dental plan during the COBRA Premium Period, then, within 30 calendar days after the termination of the plan, the Company will make a single lump sum cash payment to Executive equal to the cost that the Company otherwise
would have incurred hereunder (in the absence of the termination of the plan) to subsidize Executive’s COBRA Premiums for the period of time from the effective date of termination of the plan through the last day of the COBRA Premium Period.

 (d) Equity Awards. Solely for purposes of determining Executive’s rights with respect to the outstanding equity awards held
by Executive as of the Separation Date under the Company’s equity compensation plans: (i) Executive’s employment shall be deemed to have terminated employment as a result of a “reduction-in-force” for purposes of determining
the vesting treatment of Executive’s service-based restricted share unit awards and performance-based restricted share unit awards, (ii) Executive shall be entitled to accelerated vesting of the portion of his stock options granted on
December 1, 2015 that otherwise would have vested had his employment continued through December 1, 2016, and (iii) all vested stock options (including those that vest pursuant to the operation of this Section 3(d)) shall remain
exercisable until the earlier of three years after the Separation Date or the expiration of the remainder of the stated ten-year term. The Parties acknowledge and agree that Exhibit B provides a complete and accurate listing of all
outstanding equity awards held by Executive as of the Effective Date (the “Equity Awards”), along with the applicable pro-ration factors for Executive’s restricted share units, and the number of vested shares underlying
Executive’s stock options. Any vested restricted share units as a result of this Agreement will be paid to Executive in accordance with the terms, and subject to the conditions, of the applicable award agreements, including the 6-month delay on
payouts for service-based restricted share units. The Company shall have no obligation to grant additional equity compensation awards to the Executive for the 2016-2017 long-term equity program grant cycle or any subsequent cycle and will not grant
such awards to Executive. 
 (e) Career Transition Services. For up to one-year following the Separation Date, Executive will be
entitled to participate in the Company’s outplacement assistance 

  
 3 

 
program for officers and senior executives, with outplacement services provided by the Company’s selected outplacement services provider, and subject to the same terms and conditions as
applicable to Company officers and senior executives in the event of a reduction-in-force. 
 4. Release of Claims. Executive agrees
that, as a condition to Executive’s right to receive the payments and benefits set forth in Section 3 of this Agreement, within 21 calendar days following the Separation Date (the “Release Period”), Executive shall execute
and deliver the Release to the Company. If Executive fails to execute and deliver the Release to the Company during the Release Period, or if the Release is revoked by Executive or otherwise does not become effective and irrevocable in accordance
with its terms, then Executive will not be entitled to any payment or benefit under Section 3 of this Agreement. 
 5. Effect on
Other Severance Arrangements. Executive acknowledges that the payments and arrangements contained in this Agreement will constitute full and complete satisfaction of any and all amounts properly due and owing to Executive as a result of his
employment with the Company and its affiliates and the termination thereof. Except as provided in the immediately following sentence, Executive agrees that, as of the Effective Date, this Agreement supersedes and replaces the severance terms under
any plan, program, policy or practice or contract or agreement of the Company and its affiliates, and that Company and its affiliates have no further obligations to Executive under any plan, program, policy or practice or contract or agreement,
including without limitation, the Company’s Reduction-In-Force Program and the Company’s Change in Control Severance Plan (the “CIC Plan”). The Parties acknowledge and agree that, as of the Effective Date, Executive shall
no longer participate in the CIC Plan and Executive shall have no right to benefits under the CIC Plan; provided, however, that if a change in control (as defined in the CIC Plan) is initiated on or prior to the Effective Date, then this Agreement
shall be null and void without further action or notice and Executive’s right to severance benefits will be governed by the terms and subject to the conditions of the CIC Plan. 

6. Covenants and Restrictions. 

(a) Confidential Information and Trade Secrets. The Parties acknowledge and agree that, (i) Executive had access to the most
confidential and proprietary information and highest level trade secrets of the Company, (ii) Executive participated in the development of the Company’s strategic plans and possess knowledge of technical innovations, (iii) Executive
has managed strategic relationships with key Company clients and prospects and acquired detailed knowledge of the business plans and unreported information about the Company’s customers, (iv) Executive hired and assisted in the personal
development of key employees, (v) the Company invested considerable resources in Executive’s training and executive development, and significant resources in the development of the trade secret information and documents in which Executive
was personally involved, and (vi) throughout Executive’s employment, the Company took the necessary and appropriate steps to safeguard the disclosure or use of this confidential information outside the Company. Executive acknowledges and
agrees that (A) he is subject to the confidentiality and non-disclosure provisions of the offer letter between Executive and the Company dated September 20, 2007, as amended December 22, 2008 (the “Offer Letter”), in
which he agreed not to disclose the Company’s trade secrets or confidential 

  
 4 

 
information during or following the termination of employment, and (B) state law and federal law (the Economic Espionage Act) also prohibit the unlawful use or misappropriation of
confidential or trade secret information. Executive hereby specifically reaffirms his obligations under these contractual and statutory provisions not to disclose, use, or otherwise leverage any Company confidential, proprietary or trade secret
information or related documents in any capacity. For purposes of this Section 6, the term “Company” means the Company and its affiliates. 

(b) Non-Competition; Non-Solicitation. As a condition of receiving the Equity Awards and accepting benefits thereunder, Executive
agreed in the award agreements governing the Equity Awards (the “Equity Agreements”) that during his employment with the Company and, to the extent permitted by applicable law, for a period of 12 months after the Separation Date (or
if applicable law mandates a maximum time that is shorter than twelve months, then for a period of time equal to that shorter maximum period), regardless of the reason for termination, Executive will not, without the prior written consent of the
Chief Executive Officer of the Company: (i) render services directly or indirectly to, or become employed by, any Competing Organization (as defined below) to the extent such services or employment involves the development, manufacture,
marketing, sale, advertising or servicing of any product, process, system or service which is the same or similar to, or competes with, a product, process, system or service manufactured, sold, serviced or otherwise provided by the Company to its
customers and upon which Executive worked or in which Executive participated during the last 2 years of employment with the Company; (ii) directly or indirectly recruit, hire, solicit or induce, or attempt to induce, any exempt employee of the
Company to terminate his or her employment with or otherwise cease his or her relationship with the Company; or (iii) solicit the business of any firm or company with which Executive worked during the preceding 2 years while employed by the
Company, including customers of the Company (Sections 6(b)(i)-(iii) collectively, the “Restrictive Covenants”). The Equity Agreements provide that if Executive breaches any of the Restrictive Covenants, then in addition to any
liability Executive may have for damages arising from such breach, and to the extent permitted under applicable law: (A) any unvested restricted share units will be immediately forfeited, and, to the extent permitted by applicable law,
Executive agreed to pay to the Company the fair market value of any share units that vested and that were paid during the 12 months prior to the Separation Date, (B) performance-based restricted share units would be forfeited if the breach
occurred prior to the end of a performance period and Executive would not receive the pro-rata portion of the payout based on actual performance results, and (C) Executive’s outstanding stock options will be cancelled, and Executive will
pay to the Company the excess of the fair market value on the date of exercise over the exercise price of any option shares received in connection with the exercise of a stock option on or after the date which is 12 months prior to the date of the
breach. Executive agrees that if he breaches any of the Restrictive Covenants or any of the terms of this Section 6, the Company is entitled to seek all of the remedies provided in the Equity Agreements and any other remedies available to it.
For the sake of clarity, the Restrictive Covenants will control and are subject to enforcement in lieu of the non-competition and non-solicitation restrictions contained in the Offer Letter. 

(c) Competing Organization. As used in this Section 6, “Competing Organization” means an organization identified
as a Competing Organization by the Chief Executive Officer as set forth on Exhibit C and incorporated herein, and any other person or 

  
 5 

 
organization which is engaged in or about to become engaged in research on or development, production, marketing, leasing, selling or servicing of a product, process, system or service which is
the same or similar to or competes with a product, process, system or service manufactured, sold, serviced or otherwise provided by the Company to its customers; subject to any exceptions as granted in writing by the Chief Executive Officer, in the
Chief Executive Officer’s sole discretion, which grants shall not be unreasonably withheld. 
 (d) Insider Trading Policy. Under
federal securities laws and the Company’s insider trading policy (CMP #922 (Insider Trading)), Executive is prohibited from trading in Company securities while in possession of material, inside information about the Company. Given
Executive’s current position with the Company, he has access to highly-confidential and material information regarding the Company’s results, financial outlook and strategic business plans. As a result, until the Separation Date, Executive
will be considered a restricted insider who is required to pre-clear all trades in Teradata stock prior to the Separation Date pursuant to the Company’s insider trading policy. 

(e) Stock Ownership Guidelines. Executive shall cease to be subject to the Company’s Stock Ownership Guidelines, effective as of
the Effective Date. 
 (f) Non-Disparagement. Executive agrees to refrain from publishing or providing any oral or written statements
about the Company, its affiliates, or any of their officers, directors, managers, employees, agents or representatives that are disparaging, slanderous, libelous or defamatory, or that disclose private or confidential information about their
business affairs, or that constitute an intrusion into their private lives, or that give rise to unreasonable publicity about their private lives, or that place them in a false light before the public, or that constitute a misappropriation of their
name or likeness. Neither the Company nor its affiliates shall publish or provide any oral or written statements about Executive that are disparaging, slanderous, libelous or defamatory, or that disclose private or confidential information about
Executive’s business or personal affairs, or that constitute an intrusion into Executive’s private life, or that give rise to unreasonable publicity about Executive’s private life, or that place Executive in a false light before the
public or that constitute a misappropriation of Executive’s name or likeness. 
 (g) Return of Property and Information.
Executive acknowledges that confidential information is the exclusive property of the Company. On or before the Separation Date, or at the request of the Company at any time, Executive shall promptly return to the Company all property then in
Executive’s possession, custody or control belonging to the Company, including all confidential information; provided, however, that (i) Executive shall be entitled to keep his Company-issued mobile telephone and personal computer (subject
to the removal of all files and information contained therein by the Company, to its sole satisfaction, within a reasonable period of time following the Separation Date), and (ii) the Company shall cooperate with Executive as necessary to
permit Executive to retain for his personal purposes the telephone number currently associated with his Company-issued mobile telephone. Executive shall not retain any copies of correspondence, memorandum, reports, notebooks, drawings, photographs
or other documents in any form whatsoever (including information contained in computer or other electronic memory or on any computer or electronic storage device) relating in any way to the affairs of the Company and which were entrusted to
Executive or obtained by 

  
 6 

 
Executive at any time during Executive’s employment with the Company. Executive shall retain in his sole possession his personal computer, phone and phone number with the understanding that
any personal information obtained by the Company from such devices shall be held by the Company in confidence. 
 7. Miscellaneous.

 (a) Section 409A. The intent of the Parties is that payments and benefits under this Agreement comply with Section 409A
of the Internal Revenue Code of 1986, as amended (“Section 409A”), or are exempt therefrom and, accordingly, to the maximum extent permitted, this Agreement will be interpreted and administered so as to be in compliance therewith.
For purposes of Section 409A, each installment paid pursuant to Section 3 of this Agreement shall be treated as a separate payment. If Executive notifies the Company (with specificity as to the reason therefor) that Executive believes that
any provision of this Agreement would cause Executive to incur any additional tax or interest under Section 409A and the Company concurs with such belief or the Company (without any obligation whatsoever to do so) independently makes such
determination, the Company will, after consulting with Executive, reform such provision in a manner that is economically neutral to the Company to attempt to comply with Section 409A through good faith modifications to the minimum extent
reasonably appropriate to conform with Section 409A. The Parties hereby acknowledge and agree that the payments and benefits due to Executive under Section 3 above are payable or provided on account of Executive’s “separation
from service” within the meaning of Section 409A. Notwithstanding any provision of this Agreement to the contrary, if Executive is determined by the Company to be a “specified employee” within the meaning of Section 409A,
then any payment under this Agreement that is considered nonqualified deferred compensation subject to Section 409A will be paid no earlier than (1) the date that is six months after the date of Executive’s separation from service, or
(2) the date of Executive’s death. In no event may Executive, directly or indirectly, designate the calendar year of any payment under this Agreement. 

(b) Withholding. The Company or its affiliates, as applicable, may withhold from any amounts payable or benefits provided under this
Agreement such federal, state, local, foreign or other taxes as will be required to be withheld pursuant to any applicable law or regulation. Notwithstanding the foregoing, Executive will be solely responsible and liable for the satisfaction of all
taxes, interest and penalties that may be imposed on Executive in connection with this Agreement (including any taxes, interest and penalties under Section 409A), and neither the Company nor its affiliates will have any obligation to indemnify
or otherwise hold Executive harmless from any or all of such taxes, interest or penalties. 
 (c) Severability. In construing this
Agreement, if any portion of this Agreement will be found to be invalid or unenforceable, the remaining terms and provisions of this Agreement will be given effect to the maximum extent permitted without considering the void, invalid or
unenforceable provision. 
 (d) Successors. This Agreement is personal to Executive and without the prior written consent of the
Company will not be assignable by Executive; provided, however that this Agreement will inure to the benefit of and be enforceable by Executive’s surviving spouse, or, if she fails to survive him, by his surviving children. This Agreement will
inure to the benefit of and be binding upon the Company and its affiliates, and their respective successors and assigns. 

  
 7 

 (e) Final and Entire Agreement; Amendment. This Agreement, together with the Exhibits and
the Equity Agreements, represents the final and entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior agreements, negotiations and discussions between the Parties hereto and/or their respective
counsel with respect to the subject matter hereof. Executive has not relied upon any representations, promises or agreements of any kind except those set forth herein in signing this Agreement. Any amendment to this Agreement must be in writing,
signed by duly authorized representatives of the Parties, and stating the intent of the Parties to amend this Agreement. 
 (f) Governing
Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Ohio, without reference to conflict of laws principles. Each Party agrees that any dispute related to this Agreement or the Equity
Agreements will be subject to resolution through the Company’s Internal Dispute Resolution provisions, including final stage arbitration rather than litigation, as set forth in the Company’s internal policies and the Equity Agreements. In
the event that the Company is required to enforce its rights in a court of law, each Party (i) agrees that any action shall be brought exclusively in the courts of the State of Ohio or of the United States of America for the Southern District
of Ohio, (ii) accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of those courts, and (iii) irrevocably waives any objection, including, without limitation, any objection to the laying of
venue or based on the grounds of forum non conveniens, which it may now or hereafter have to the bringing of any action in those jurisdictions. 

(g) Notices. All notices and other communications hereunder will be in writing and will be given by hand delivery or via e-mail to the
other Party or by registered or certified mail, return receipt requested, postage prepaid, or by overnight courier, addressed as follows: 

If to Executive: at Executive’s most recent address on the records of the Company; 

If to the Company: 
 General
Counsel/Notices 
 Teradata Corporation 

10000 Innovation Drive 

Miamisburg, Ohio 45342 
 Attn:
Legal Notices 
 Email: Law.notices@teradata.com 

or to such other address as either Party will have furnished to the other in writing in accordance herewith. Notice and communications will be effective on
the date of delivery if delivered by hand or e-mail, on the first business day following the date of dispatch if delivered utilizing overnight courier, or three business days after having been mailed, if sent by registered or certified mail. 

  
 8 

 (h) Counterparts. This Agreement may be executed in one or more counterparts (including by
means of facsimile or other electronic transmission), each of which will be deemed an original, but all of which taken together will constitute one original instrument. 

(i) Representation By Counsel. Each of the Parties acknowledges that it or he has had the opportunity to consult with legal counsel of
his choice prior to the execution of this Agreement. Without limiting the generality of the foregoing, Executive acknowledges that he has had the opportunity to consult with his own independent legal counsel to review this Agreement for purposes of
compliance with the requirements of Section 409A or an exemption therefrom, and that he is relying solely on the advice of his independent legal counsel for such purposes. Moreover, the Parties acknowledge that they have participated jointly in
the negotiation and drafting of this Agreement. If any ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise
favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement. 
 IN WITNESS WHEREOF, the Parties
hereto have each executed this Agreement as of the date first above written. 
  

			
	TERADATA CORPORATION
		
	By:	 	 
		
	Its:	 	 
	
	EXECUTIVE
	
	  
 Robert
Fair

  
 9 

 EXHIBIT A 

RELEASE OF CLAIMS 
 I have
been notified my employment with Teradata Corporation (“Teradata”) will be terminated. In exchange for severance benefits provided under the Separation Agreement between myself and Teradata dated August 1, 2016 (the
“Separation Agreement”), I acknowledge and agree to the following: 
  

	1.	I may sign and submit this Release of Claims (“Release”) at any time during the 21 days after my termination. 

  

	2.	I understand this Release does not constitute an admission by Teradata of any liability, violation of any federal or state laws, or any other civil wrong. 

 

	3.	I may revoke this Release during the seven days after I sign it by delivering written notice to Teradata in accordance with Section 5(e) of the Agreement no later than the close of business on the seventh day after
signature. This Release will not become effective or enforceable until the expiration of that seven-day period. I understand that my severance benefits will be processed after the expiration of the seven-day period. 

 

	4.	I release and discharge Teradata, its affiliates, successors, and each of their fiduciaries, stockholders, directors, officers, agents, and employees (“Released Parties”), from all claims, causes of
action, suits, damages, rights to monetary or equitable relief, known or unknown, including access to Teradata’s internal dispute resolution process, for anything occurring up to and including the date on which I sign this Release. Without
limiting the prior sentence, this release covers all claims I have, have ever had, or may now have, for or related in any way to my employment or the end of my employment with the Company, including but not limited to all claims for age
discrimination under the Age Discrimination in Employment Act; Title VII of the Civil Rights Act of 1964; the Family and Medical Leave Act; the Employee Retirement Income Security Act (“ERISA”), any similar state or local Fair
Employment statute or ordinance; any claim of wrongful discharge, discrimination, harassment, retaliation, breach of implied or express promises, defamation, invasion of privacy and intentional or negligent infliction of emotional distress; all
claims for lost or unpaid wages, overtime, bonuses, or statutory penalties; and any claims of coverage under any of Teradata’s commercial automobile liability insurance policies. 

Without limiting the foregoing Paragraph, I represent that I understand that this Release specifically releases and waives any claims of age
discrimination, known or unknown, that I may have against the Released Parties as of the date I sign this Agreement. This Release specifically includes a waiver of rights and claims under the Age Discrimination in Employment Act of 1967, as
amended, and the Older Workers Benefit Protection Act. I acknowledges that as of the date I sign this Release, I may have certain rights or claims under the Age Discrimination in Employment Act, 29 U.S.C. §626 and I voluntarily
relinquishes any such rights or claims by signing this Release. 

	5.	Teradata advises me to consult with an attorney prior to signing this Release. By signing this Release I understand I am giving up and waiving legal rights. I have either freely chosen not to consult with an attorney
or I have decided to sign after discussing this Release with my attorney. 

  

	6.	This Release does not prevent me from: (a) responding accurately and fully to any question, inquiry or request for information when required by legal process; (b) disclosing information to regulatory bodies;
or (c) filing a charge with the Equal Employment Opportunity Commission concerning claims of discrimination or participating in any manner in an investigation, hearing or proceeding or affect the rights of the EEOC to enforce the civil rights
laws. However, I waive my right to recover any damages or other relief in any claim or suit brought by any federal agency, such as the EEOC or any state or local agency, on my behalf, under Title VII of the Civil Rights Act of 1964, the Age
Discrimination in Employment Act (ADEA), the Americans with Disabilities Act (ADA), the Equal Pay Act, or any other federal, state or municipal discrimination law. 

 

	7.	As used in this Release, “Teradata” includes its parents, subsidiaries, affiliates, divisions, past and present directors, officers, agents and employees. 

 

	8.	This Release and the Agreement represent the entire agreement between me and Teradata relating to the end of my employment and, with the exception of any agreements relating to arbitration of employment-related
disputes, or trade secrets and preserving the confidentiality of Teradata information, supersedes all prior written or oral understandings, statements or agreements. 

I have read this Release and I understand its terms. I enter into and sign this Release knowingly, voluntarily, and with full knowledge of its contents. 

 

							
	  
 Signature of Associate
	  	  
 Social Security Number
	  	  
 Non-Teradata E-mail

Address
	  	  
 Date

				
	  
 Associate Name (Printed)
	  	  
 Associate QuickLook ID
	  	  
 Non-Teradata Telephone
Number
	  	

 Human Resources Acknowledgment of Receipt: 
  

					
	  
 Human Resources
Representative
	  	  
 Title
	  	  
 Date

  
 A-2 

 NOTE: The original document, when signed by both employee and Human Resources Representative should be
returned to the Teradata HR Service Center, for inclusion in the employee’s Personnel File. 
 Teradata HR Service Center 

10000 Innovation Drive 
 Dayton, Ohio 45342 

  
 A-3 

 EXHIBIT B 

TREATMENT OF OUTSTANDING EQUITY AWARDS 

Bob Fair 
 Outstanding Equity as of 7/20/2016 

 

																							
	 	 	 	 	 	 	 	 	 	 	Current Equity Position	 	 	 	Standard Proration Treatment
	 GRANT

DATE
	 	AWARD
TYPE	 	VESTING	 	FMV ON
GRANT
DATE	 	QTY-
GRANTED	 	QTY
OUTSTANDING	 	QTY
VESTED	 	QTY
UNVESTED	 	Assumed
Last Day
Worked	 	Standard
Pro-Rata
Months	 	Standard Pro-Rata
Shares Vesting /
Options Retained	 	Standard Pro-Rata
Shares/Options
Forfeited
	12/3/2013	 	RU	 	3 yr cliff	 	$45.35	 	6,716	 	6,716	 	0	 	6,716	 	11/1/2016	 	36	 	6,716	 	0
	12/1/2014	 	RU	 	3 yr graded	 	$44.43	 	13,693	 	9,129	 	0	 	9,129	 	11/1/2016	 	12	 	4,565	 	4,564
	2/27/2015	 	RU	 	3 yr graded	 	$44.52	 	16,812	 	11,208	 	0	 	11,208	 	11/1/2016	 	10	 	4,670	 	6,538
	12/1/2015	 	RU	 	3 yr graded	 	$30.63	 	31,870	 	31,870	 	0	 	31,870	 	11/1/2016	 	12	 	10,623	 	21,247
	12/10/2012	 	PBRSU	 	Q1 2017	 	$58.63	 	28,000	 	28,000	 	0	 	28,000	 	11/1/2016	 	47	 	tbd	 	tbd
	3/1/2013	 	PBRSU	 	Q1 2017	 	$58.56	 	12,000	 	12,000	 	0	 	12,000	 	11/1/2016	 	47	 	tbd	 	tbd
	2/9/2015	 	1 yr
 PBRSU
	 	3 yr graded	 	$44.43	 	1,369	 	913	 	0	 	913	 	11/1/2016	 	10	 	380	 	533
	12/1/2015	 	1 yr
 PBRSU
	 	Q1 2017	 	$30.63	 	26,558	 	26,558	 	0	 	26,558	 	11/1/2016	 	11	 	tbd	 	tbd
	12/1/2015	 	3 yr
 PBRSU
	 	Q1 2019	 	$30.63	 	26,558	 	26,558	 	0	 	26,558	 	11/1/2016	 	11	 	tbd	 	tbd
	10/1/2007	 	SO	 	25%, 4 yr	 	$27.98	 	25,376	 	15,376	 	15,376	 	0	 	11/1/2016	 	n/a	 	15,376	 	0
	12/2/2008	 	SO	 	25%, 4 yr	 	$13.77	 	135,922	 	110,922	 	110,922	 	0	 	11/1/2016	 	n/a	 	110,922	 	0
	12/1/2009	 	SO	 	25%, 4 yr	 	$30.68	 	41,963	 	41,963	 	41,963	 	0	 	11/1/2016	 	n/a	 	41,963	 	0
	11/30/2010	 	SO	 	25%, 4 yr	 	$41.09	 	39,819	 	39,819	 	39,819	 	0	 	11/1/2016	 	n/a	 	39,819	 	0
	11/29/2011	 	SO	 	25%, 4 yr	 	$50.70	 	28,606	 	28,606	 	28,606	 	0	 	11/1/2016	 	n/a	 	28,606	 	0
	11/27/2012	 	SO	 	25%, 4 yr	 	$61.55	 	26,122	 	26,122	 	19,591	 	6,531	 	11/1/2016	 	n/a	 	19,591	 	6,531
	12/3/2013	 	SO	 	25%, 4 yr	 	$45.35	 	34,816	 	34,816	 	17,408	 	17,408	 	11/1/2016	 	n/a	 	17,408	 	17,408
	12/1/2014	 	SO	 	25%, 4 yr	 	$44.43	 	33,883	 	33,883	 	8,470	 	25,413	 	11/1/2016	 	n/a	 	8,470	 	25,413
	12/1/2015	 	SO	 	25%, 4 yr	 	$30.63	 	59,166	 	59,166	 	0	 	59,166	 	11/1/2016	 	1 month
 accelerated

vesting
	 	14,791	 	44,375
		 		 		 		 		 		 	282,155	 	261,470	 		 		 	323,900	 	126,609

 Notes: 

• This data is as of July 20, 2016. Actual equity treatment applied will be based on current shares outstanding at the time of separation according
to the approved terms. 
 • The 12/10/2012 PBRSU (known as the Special 2016 Performance Award) and the 3/1/2013 PBRSU (known as the Special 2016
Long-Term Strategic Award) are expected to be certified at 0%payout in Q1 2017. 
 • The 12/1/2015 PBRSUs, known as the 2016 Annual EPS PBRSU and
2016-2018 TSR PBRSU, will be certified for any applicable payout in Q1 2017 and Q1 2019 respectively. The units earned from either of these PBRSUs, if any, will be paid out on pro-rata basis pursuant to the terms of the award agreement. 

 EXHIBIT C 

COMPETING ORGANIZATIONS 
 For purposes of
the restrictive covenant provisions in Teradata compensation plans and agreements that refer to “Competing Organizations” as identified by the Chief Executive Officer, the following companies, including their operating subsidiaries, are
identified as “Competing Organizations”, excluding any company on the list below that Teradata’s Chief Executive Officer determines to be engaged primarily in the business of marketing applications and related services: 

COMPETING ORGANIZATIONS 
 Accenture 

Actian Corporation 
 Amazon.com, Inc. 

Cognizant Technology Solutions Corp. 
 EMC Corporation (including
Greenplum) 
 Hewlett Packard (HP) (including Vertica) 
 IBM
(including Netezza and Unica) 
 Oracle Corporation (including Responsys) 

SAP (including Sybase) 
 SAS Institute, Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]